New mitochondrial DNA synthesis enables NLRP3 inflammasome activation

Area of Science:

• Immunology
• Molecular Biology
• Cellular Biology

Background:

• Dysregulated NLRP3 inflammasome activity drives chronic inflammation and disease.
• Mitochondrial damage is known to be necessary for NLRP3 inflammasome activation.
• The precise mechanisms by which macrophages sense diverse NLRP3 activators remain unclear.

Purpose of the Study:

• To elucidate the role of mitochondrial DNA (mtDNA) synthesis in NLRP3 inflammasome activation.
• To identify the molecular pathways linking Toll-like receptor (TLR) engagement to NLRP3 signaling.
• To explore potential therapeutic strategies targeting NLRP3 inflammasome-associated diseases.

Main Methods:

• Investigated the role of Toll-like receptors (TLRs) and their adaptors (MyD88, TRIF) in initiating NLRP3 signaling.
• Analyzed the IRF1-dependent transcription of CMPK2 and its impact on deoxyribonucleotide synthesis.
• Examined the necessity of CMPK2-dependent mtDNA synthesis for producing oxidized mtDNA fragments.
• Assessed the association of cytosolic oxidized mtDNA with the NLRP3 inflammasome complex.

Main Results:

• Toll-like receptor engagement induces mitochondrial DNA (mtDNA) synthesis via IRF1-dependent CMPK2 transcription.
• CMPK2-dependent mtDNA synthesis is critical for generating oxidized mtDNA fragments upon NLRP3 activation.
• Cytosolic oxidized mtDNA fragments directly associate with and are required for NLRP3 inflammasome activation.
• CMPK2 catalytic activity is identified as a key regulatory point in NLRP3 inflammasome signaling.

Conclusions:

• Mitochondrial DNA synthesis, orchestrated by CMPK2, is a crucial upstream event for NLRP3 inflammasome activation.
• Oxidized mtDNA fragments serve as a key signal linking TLR engagement to inflammasome assembly.
• Targeting CMPK2 activity presents a promising therapeutic avenue for managing chronic inflammatory diseases driven by NLRP3 inflammasome.